Sort
8,912 grants matching “sars cov 2”
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
$677,874John A Dodson · New York University School Of Medicine · R01 · FY2023 · AG
Single-cell Analysis of Normal and Perturbed Dynamic Biological Systems
$677,833Benedict Anchang · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Coronavirus Genome Replication
$677,301Craig E. Cameron · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Community-based Design and Evaluation of a Conversational Agent to Promote SARS-COV2 Vaccination in Black Churches
$677,130Timothy W Bickmore · Northeastern University · R01 · FY2024 · MD
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
$676,523Chunhua Weng · Columbia University Health Sciences · R01 · FY2024 · LM
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
$676,523Chunhua Weng · Columbia University Health Sciences · R01 · FY2025 · LM
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19
$676,257Jie Sun · University Of Virginia · R01 · FY2025 · HL
Coronavirus Genome Replication
$676,030Craig E. Cameron · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients
$675,830Heidi M. Crane · University Of Washington · R01 · FY2024 · HL
Coronavirus Genome Replication
$675,803Craig E. Cameron · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Mitigating Adverse Effects of COVID-19 through Preventive Interventions for Families with Young Children Living in Poverty: Linking Data from 3 Cities with Diverse Risks and Exposures
$675,775Alan L Mendelsohn · New York University School Of Medicine · R01 · FY2024 · HD
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
$675,714Argentina Elisa Noelle Servin · University Of California, San Diego · R01 · FY2021 · MD
Antibody repertoire characterization in the context of coronaviruses
$675,447Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2020 · AI
Adaptive Immunity and Persistent SARS-CoV-2 Replication
$675,412Suresh B Boppana · University Of Alabama At Birmingham · U01 · FY2022 · CA
Quantitative Immunological Assays to Assess Coronavirus Antibodies and Vaccines
$675,181Nicole Doria-Rose · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease
$675,181Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Research Core 1: Molecular Measures Core (RC1)
$674,676Virginia B. Kraus · Duke University · P30 · FY2024 · AG
Development of an Oral Pan-Coronavirus Drug Cocktail
$674,611Stephen J. Polyak · University Of Washington · R01 · FY2024 · AI
Role of Complement Activation in Severe COVID-19
$674,370Xuebin Qin · Tulane University Of Louisiana · R01 · FY2025 · HL
Role of Complement Activation in Severe COVID-19
$674,314Xuebin Qin · Tulane University Of Louisiana · R01 · FY2023 · HL
Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility
$673,720Sanjana Dayal · University Of Iowa · R01 · FY2024 · AI
Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility
$673,720Sanjana Dayal · University Of Iowa · R01 · FY2023 · AI
Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility
$673,720Sanjana Dayal · University Of Iowa · R01 · FY2022 · AI
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
$673,696David A. Zidar · Case Western Reserve University · U01 · FY2022 · CA
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up
$673,573Gloria D Coronado · Kaiser Foundation Research Institute · R01 · FY2021 · CA